annual EBIT:
-$223.61M-$76.84M(-52.36%)Summary
- As of today (July 1, 2025), KYMR annual earnings before interest & taxes is -$223.61 million, with the most recent change of -$76.84 million (-52.36%) on December 31, 2024.
- During the last 3 years, KYMR annual EBIT has fallen by -$123.57 million (-123.52%).
- KYMR annual EBIT is now -942.42% below its all-time high of -$21.45 million, reached on December 31, 2018.
Performance
KYMR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$65.51M+$5.18M(+7.33%)Summary
- As of today (July 1, 2025), KYMR quarterly earnings before interest & taxes is -$65.51 million, with the most recent change of +$5.18 million (+7.33%) on March 31, 2025.
- Over the past year, KYMR quarterly EBIT has dropped by -$17.02 million (-35.10%).
- KYMR quarterly EBIT is now -723.18% below its all-time high of -$7.96 million, reached on September 30, 2020.
Performance
KYMR quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$240.63M-$17.02M(-7.61%)Summary
- As of today (July 1, 2025), KYMR TTM earnings before interest & taxes is -$240.63 million, with the most recent change of -$17.02 million (-7.61%) on March 31, 2025.
- Over the past year, KYMR TTM EBIT has dropped by -$86.25 million (-55.87%).
- KYMR TTM EBIT is now -2007.83% below its all-time high of -$11.42 million, reached on September 30, 2019.
Performance
KYMR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KYMR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.4% | -35.1% | -55.9% |
| 3 y3 years | -123.5% | -78.8% | -94.6% |
| 5 y5 years | -442.7% | -501.1% | -403.8% |
KYMR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.5% | at low | -357.6% | +7.3% | -72.8% | at low |
| 5 y | 5-year | -442.7% | at low | -723.2% | +7.3% | -443.1% | at low |
| alltime | all time | -942.4% | at low | -723.2% | +7.3% | -2007.8% | at low |
KYMR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$65.51M(-7.3%) | -$240.63M(+7.6%) |
| Dec 2024 | -$223.61M(+52.4%) | -$70.69M(+13.2%) | -$223.61M(+33.7%) |
| Sep 2024 | - | -$62.43M(+48.6%) | -$167.23M(+6.1%) |
| Jun 2024 | - | -$42.00M(-13.4%) | -$157.63M(+2.1%) |
| Mar 2024 | - | -$48.49M(+238.7%) | -$154.38M(+5.2%) |
| Dec 2023 | -$146.77M(-5.1%) | -$14.32M(-72.9%) | -$146.77M(-12.3%) |
| Sep 2023 | - | -$52.83M(+36.3%) | -$167.26M(+6.3%) |
| Jun 2023 | - | -$38.75M(-5.2%) | -$157.40M(-0.9%) |
| Mar 2023 | - | -$40.87M(+17.4%) | -$158.86M(+2.7%) |
| Dec 2022 | -$154.63M | -$34.81M(-19.0%) | -$154.63M(+0.6%) |
| Sep 2022 | - | -$42.97M(+6.8%) | -$153.67M(+10.4%) |
| Jun 2022 | - | -$40.22M(+9.8%) | -$139.22M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$36.64M(+8.3%) | -$123.64M(+23.6%) |
| Dec 2021 | -$100.04M(+120.0%) | -$33.85M(+18.7%) | -$100.04M(+26.9%) |
| Sep 2021 | - | -$28.51M(+15.8%) | -$78.85M(+35.3%) |
| Jun 2021 | - | -$24.63M(+88.7%) | -$58.30M(+22.4%) |
| Mar 2021 | - | -$13.05M(+3.1%) | -$47.63M(+4.7%) |
| Dec 2020 | -$45.48M(+10.4%) | -$12.66M(+59.1%) | -$45.48M(+2.7%) |
| Sep 2020 | - | -$7.96M(-43.0%) | -$44.30M(-7.2%) |
| Jun 2020 | - | -$13.96M(+28.1%) | -$47.76M(+41.3%) |
| Mar 2020 | - | -$10.90M(-5.1%) | -$33.80M(+47.6%) |
| Dec 2019 | -$41.20M(+92.1%) | -$11.48M(+0.6%) | -$22.90M(+100.6%) |
| Sep 2019 | - | -$11.42M | -$11.42M |
| Dec 2018 | -$21.45M | - | - |
FAQ
- What is Kymera Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics annual EBIT year-on-year change?
- What is Kymera Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly EBIT year-on-year change?
- What is Kymera Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Kymera Therapeutics?
- What is Kymera Therapeutics TTM EBIT year-on-year change?
What is Kymera Therapeutics annual earnings before interest & taxes?
The current annual EBIT of KYMR is -$223.61M
What is the all time high annual EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high annual earnings before interest & taxes is -$21.45M
What is Kymera Therapeutics annual EBIT year-on-year change?
Over the past year, KYMR annual earnings before interest & taxes has changed by -$76.84M (-52.36%)
What is Kymera Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of KYMR is -$65.51M
What is the all time high quarterly EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly earnings before interest & taxes is -$7.96M
What is Kymera Therapeutics quarterly EBIT year-on-year change?
Over the past year, KYMR quarterly earnings before interest & taxes has changed by -$17.02M (-35.10%)
What is Kymera Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of KYMR is -$240.63M
What is the all time high TTM EBIT for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM earnings before interest & taxes is -$11.42M
What is Kymera Therapeutics TTM EBIT year-on-year change?
Over the past year, KYMR TTM earnings before interest & taxes has changed by -$86.25M (-55.87%)